drugset / Trial / NCT05028153

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms

NCT05028153

Phase 2 Recruiting 320 enrolled Copenhagen Studies on Asthma in Childhood
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this double-blind, randomized, controlled clinical trial is to investigate the effect of a three-day azithromycin treatment versus placebo treatment in children aged 1-5 years who are hospitalized due to asthma-like symptoms.

Timeline

Start
2022-11-14
Primary completion
2026-11-13
Completion
2032-11-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 10 mg/kg Oral

Indications